A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors
Clinical trial NCT05205109 · RECRUITING
Trial details
- NCT number
- NCT05205109
- Sponsor
- Antengene Therapeutics Limited
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-07
- Primary completion
- 2027-08-30
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.